Belite Bio Inc (BLTE)
48.22
-0.33
(-0.68%)
USD |
NASDAQ |
Sep 20, 16:00
48.22
0.00 (0.00%)
After-Hours: 20:00
Belite Bio Total Liabilities (Quarterly): 3.837M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.837M |
| March 31, 2024 | 4.677M |
| December 31, 2023 | 4.211M |
| September 30, 2023 | 4.804M |
| June 30, 2023 | 4.978M |
| Date | Value |
|---|---|
| March 31, 2023 | 4.649M |
| December 31, 2022 | 2.772M |
| June 30, 2022 | 1.426M |
| December 31, 2021 | 33.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.426M
Minimum
Jun 2022
33.44M
Maximum
Dec 2021
7.199M
Average
4.649M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.43M |
| Shareholders Equity (Quarterly) | 114.59M |